| 摘要 |
Disclosed are glucagon-like peptide-1 (GLP-1) compounds with modifications a t one or more of the following positions: 7, 8, 12, 16, 18, 19, 20, 22, 25, 27 , 30, 33, and 37. Methods of treating a subject in need of GLP-1 receptor stimulation using these GLP-1 compounds are also disclosed.
|
